杭州柯林(688611) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was CNY 37,284,193.04, representing a year-on-year increase of 22.46%[2] - The net profit attributable to shareholders for the same period was CNY 13,031,656.66, up by 20.41% compared to the previous year[2] - Basic and diluted earnings per share were both CNY 0.23, reflecting a growth of 21.05% year-on-year[2] - The company's total comprehensive income for Q1 2023 was CNY 13,031,656.66, compared to CNY 10,822,972.76 in Q1 2022, reflecting a growth of 20.0%[16] - The net profit for Q1 2023 was CNY 13,031,656.66, an increase of 20.0% compared to CNY 10,822,972.76 in Q1 2022[15] - Operating profit for Q1 2023 reached CNY 14,632,175.46, up from CNY 9,479,890.17 in the same period last year, reflecting a growth of 54.0%[15] Cash Flow - The net cash flow from operating activities increased significantly by 87.17%, totaling CNY 34,035,693.02, primarily due to the recovery of accounts receivable[5] - Cash flow from operating activities generated a net amount of CNY 34,035,693.02, significantly higher than CNY 18,183,948.28 in Q1 2022, marking an increase of 87.0%[18] - The company reported a net increase in cash and cash equivalents of CNY -227,622,662.10 for Q1 2023, compared to CNY -177,837,004.01 in Q1 2022[18] Assets and Liabilities - Total assets at the end of the reporting period were CNY 887,532,026.53, a slight increase of 1.12% from the end of the previous year[3] - The company's total assets as of March 31, 2023, were RMB 887,532,026.53, compared to RMB 877,693,811.98 at the end of 2022, indicating a growth of 1.0%[13] - The total liabilities as of March 31, 2023, were RMB 59,548,338.64, a decrease from RMB 62,741,780.75 at the end of 2022, representing a reduction of 3.5%[12] - The company's equity attributable to shareholders reached RMB 827,983,687.89 as of March 31, 2023, up from RMB 814,952,031.23 at the end of 2022, showing a growth of 1.4%[13] Research and Development - Research and development expenses amounted to CNY 7,120,890.02, which is 19.10% of operating revenue, an increase of 0.20 percentage points from the previous year[3] - Research and development expenses for Q1 2023 amounted to RMB 7,120,890.02, which is a 23.7% increase from RMB 5,753,595.99 in Q1 2022[14] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 2,202[6] - The top shareholder, Xie Dong, holds 44.79% of the shares, totaling 25,039,438 shares[7] Investment Activities - Total cash inflow from investment activities was CNY 321,482,235.77, compared to CNY 109,625,576.54 in Q1 2022, representing a growth of 194.0%[18] - The company reported a cash outflow from investment activities of CNY 583,140,590.89, which is an increase from CNY 305,648,528.83 in the previous year, indicating a rise of 91.0%[18] - The net cash flow from investment activities was negative at CNY -261,658,355.12, worsening from CNY -196,020,952.29 in Q1 2022[18] Operational Efficiency - The company reported a net profit for Q1 2023, with a profit margin improvement due to increased operational efficiency and cost management strategies[14]